DAFNA Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

DAFNA Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-305,500	Closed	-$929K	–	94
2019 Q3	$929K	Sell	305,500 -502,500	-62%	-$1.41M	0.35%	59
2019 Q2	$1.92M	Hold	808,000	–	–	0.72%	38
2019 Q1	$3.03M	Hold	808,000	–	–	1.31%	27
2018 Q4	$2.9M	Hold	808,000	–	–	1.44%	24
2018 Q3	$4.63M	Buy	808,000 +470,000	+139%	+$2.69M	1.9%	17
2018 Q2	$1.69M	Buy	338,000 +2,500	+0.7%	+$12.9K	0.79%	35
2018 Q1	$1.72M	Sell	335,500 -17,241	-5%	-$104K	0.84%	34
2017 Q4	$2.12M	Buy	352,741 +94,074	+36%	+$566K	1.14%	30
2017 Q3	$1.44M	Sell	258,667 -97,000	-27%	-$501K	0.89%	37
2017 Q2	$1.65M	Buy	355,667 +30,000	+9%	+$134K	1.18%	30
2017 Q1	$1.61M	Buy	325,667 +57,600	+21%	+$554K	1.36%	27
2016 Q4	$2.98M	Sell	268,067 -10,000	-4%	-$94.1K	2.61%	11
2016 Q3	$2.58M	Buy	278,067 +85,500	+44%	+$715K	1.79%	18
2016 Q2	$1.22M	Buy	192,567 +73,896	+62%	+$490K	0.97%	35
2016 Q1	$774K	Buy	118,671 +57,901	+95%	+$373K	0.67%	42
2015 Q4	$493K	Buy	+60,770	New	+$454K	0.44%	57

Other funds holding FOMX

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return